20 June 2013
Keywords: fda, post-marketing, surveillance, funding, food, drug, administration
Article | 11 November 1997
The US Food and Drug Administration has no system in place to dealuniformly with adverse event reporting and related matters, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.